Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$78,588,440
in 8 filings, $78.6M under 10b5-1 plans

Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-09 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion 10b5-1 +11,280 $17.76 $200K 23,977
2026-11-09 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −11,280 $98.54 $1.1M 12,697
2026-11-09 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion · Share Option 10b5-1 −11,280 5,114
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion 10b5-1 +4,689 $10.76 $50K 33,751
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion 10b5-1 +3,932 $11.10 $44K 37,683
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion 10b5-1 +7,209 $11.97 $86K 44,892
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion 10b5-1 +4,065 $17.76 $72K 48,957
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −6,030 $91.87 $554K 42,927
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −6,831 $92.77 $634K 36,096
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −9,508 $94.20 $896K 26,588
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −3,705 $94.86 $351K 22,883
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −3,145 $96.08 $302K 19,738
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −1,691 $97.11 $164K 18,047
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −5,350 $97.74 $523K 12,697
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion · Share Option 10b5-1 −3,932 0
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion · Share Option 10b5-1 −7,209 0
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion · Share Option 10b5-1 −4,689 2,983
2026-10-30 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion · Share Option 10b5-1 −4,065 16,394
2026-09-03 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −4,600 $80.30 $369K 29,062
2026-09-01 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion 10b5-1 +3,932 31,629

Page 1 of 11 · 206 trades